PRTA (Prothena Corporation plc) — Stock Analysis, Catalysts & AI Research

Prothena Corporation plc

$8.43

Health CareBiotechnology

The Read: 7% as a one-time $50M milestone failed to ease cash burn concerns despite in-line earnings.

Price

Overlays

Panel

PRTA

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Prothena Corporation plc

$8.43

Health CareBiotechnology

The Read: 7% as a one-time $50M milestone failed to ease cash burn concerns despite in-line earnings.

Price

Overlays

Panel

PRTA

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Create your free account to unlock active Expected Moves for PRTA

Expected Moves

Prothena Corporation plc

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Create your free account to unlock active Expected Moves for PRTA

Expected Moves

Prothena Corporation plc

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow